Dtsch Med Wochenschr 2007; 132(25/26): 1383-1387
DOI: 10.1055/s-2007-982039
Klinischer Fortschritt | Commentary

© Georg Thieme Verlag KG Stuttgart · New York

Intensivmedizin 2007

Intensiv care medicine 2007K. Werdan1
  • 1Universitätsklinik und Poliklinik für Innere Medizin III, Universitätsklinikum Halle der Martin-Luther-Universität Halle-Wittenberg
Further Information

Publication History

eingereicht: 29.5.2007

akzeptiert: 5.6.2007

Publication Date:
15 June 2007 (online)

Was ist neu?

  • Infarktbedingter kardiogener Schock: Spielt SIRS doch keine Rolle?

  • ARDS: Volumen- und Kortikoidtherapie

  • Sepsis und MODS: Hydrocortison enttäuscht, Selen und Statine könnten hilfreich sein.

  • Zu alt für die Intensivstation?

Literatur

  • 1 Almog Y, Novack V, Eisinger M. et al . The effect of statin therapy on infection-related mortality in patients with atheroslerotic diseases.  Crit Care Med. 2007;  35 372-378 , . Editorial: 631 - 632
  • 2 Andrews P, Azoulay E, Antonelli M. et al . Year in review in Intensive Care Medicine 2006.  Intensive Care Med. 2007;  33 49-57 , , 214 - 229, 414 - 422
  • 3 Angstwurm M WA, Engelmann L, Zimmermann T. et al . Selenium in Intensive Care (SIC): Results of a prospective, randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.  Crit Care Med. 2007;  35 118-126
  • 4 Annane D, Sébille V, Bellissant E. for the Ger-Inf-05 Study Group . Effect of low doses of corticosteroids in septic shock patients with or without early respiratory distress syndrome.  Crit Care Med. 2007;  34 22-30
  • 5 Brunkhorst F M, Werdan K. Intensivmedizin - nach den positiven Studien kommen die Fragen.  Dtsch Med Wochenschr. 2006;  131 1441-1444
  • 6 Brunner-Ziegler S, Heinze G, Ryffel M, Kompatscher M, Slany J, Valentin A. „Oldest old” patients in intensive care: prognosis and therapeutic activity.  Wien Klin Wochenschr. 2007;  119/1 - 2 14-19
  • 7 Chua D, Tsang R S, Kuo I F. The role of statin therapy in sepsis.  Ann Pharmacother. 2007;  41 647-652
  • 8 Dowdy D W, Eid M P, Dennison C R. et al . Quality of life after acute respiratory distress syndrome: a meta-analysis.  Intensive Care Med. 2006;  32 1115-1124
  • 9 Gupta R, Plantinga L C, Fink N E. et al . Statin use and hospitalization for sepsis in patients with chronic kidney disease.  JAMA. 2007;  297/13 1455-1464
  • 10 Kaarlola A, Tallgren M, Pettilä V. Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients.  Crit Care Med. 2006;  34 2120-2126
  • 11 Lipiner-Friedman D, Sprung C L, Laterre P F. et al.; for the Corticus Study Group . Adrenal function in sepsis: The retrospective Corticus cohort study.  Crit Care Med. 2007;  35 1012-1018
  • 12 Majumdar S R, McAllister F A, Eurich D T, Padwal R S, Marrie T J. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study.  BMJ. 2006;  333 999-1001 , ; Kommentare: 333: 980 - 981; 333: 1123 - 1124
  • 13 Marik P E. Management of the critically ill geriatric patient.  Crit Care Med. 2006;  (Suppl) 34 S176-S182
  • 14 Martin G S, Mannino D M, Moss M. The effect of age on the development and outcome of adult sepsis.  Crit Care Med. 2006;  34 15-21
  • 15 Martin C P, Talbert R L, Burgess D S, Peters J I. Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation.  Pharmacotherapy. 2007;  27 20-26
  • 16 Müller-Werdan U. Besonderheiten bei älteren Intensivpatientinnen und Intensivpatienten.  Arzneimittel Forschung Drug Research. 2006;  56/11 31-32
  • 17 Prondzinsky R, Lemm H, Swyter M. et al . A Prospective, Randomized Evaluation of Intraaortic Balloon Counterpulsation for the Prevention of Multiorgan-Dysfunction and -Failure in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock.  Circulation. 2006;  114/18 (Suppl I) II-555
  • 18 Schmidt  H, Hennen R, Keller A. et al . Association of statin therapy and increased survival in patients with multiple organdysfunction syndrome.  Intensive Care Med. 2006;  32 1248-1251
  • 19 Schmidt H, Hennen R, Werdan K, Buerke M. Statine: Der nächste Schritt in der adjuvanten Sepsistherapie?.  INTENSIV-NEWS. 2007;  10 1-4
  • 20 Terblanche M, Almog Y, Rosenson R S, Smith T S, Hackam D G. Statins and sepsis: multiple modifications at multiple levels.  Lancet Infect Dis. 2007;  7 358-368
  • 21 The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network . Comparison of Two Fluid-Management Strategies in Acute Lung Injury.  N England J Med. 2006;  354 2564-2575 , ; Editorial: 2598 - 2600
  • 22 The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network . Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome.  N Engl J Med. 2006;  354 1671-1684
  • 23 The TRIUMPH Investigators . Effect of Tilarginine Acetate in Patients with Myocardial Infarction and Cardiogenic Shock - The TRIUMPH Randomized and Controlled Trial.  JAMA. 2007;  297 1657-1666
  • 24 Torres O H, Francia E, Longobardi V, Gich I, Benito S, Ruiz D. Short- and longterm outcomes of older patients in intermediate care units.  Intensive Care Med. 2006;  32 1052-1059
  • 25 Vincent J -L, Sakr Y, Sprung C L. et al.; on behalf of the Sepsis Occurrence in Acutely Ill Patients Investigators . Sepsis in European intensive care units: Results of the SOAP study.  Crit Care Med. 2006;  34 344-353

Prof. Dr. med. Karl Werdan

Universitätsklinik und Poliklinik für Innere Medizin III, Universitätsklinikum Halle der Martin-Luther-Universität Halle-Wittenberg

Ernst-Grube-Straße 40

06096 Halle (Saale)

Phone: 0345/5572601

Fax: 0345/5572072

Email: karl.werdan@medizin.uni-halle.de

    >